The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor
Yuan Yang(Shenyang Pharmaceutical University), Lihui Wang(Shenyang Pharmaceutical University)
Cited by 9
Related Papers
Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity
|Cell Death and Disease|2017|134
An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer
|Molecular Cancer|2022|62
<p>LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis</p>
|OncoTargets and Therapy|2019|25